Verastem, Inc. (VSTM)

Analysts 3
Positive
100%
Median target $10 (115% upside)


    • 09/07/17
      H.C. Wainwright
      buy
      $10
    • 09/06/17
      Oppenheimer
      outperform
      $6
      "The results of the DUO study released today are highly positive and support our assumptions for..."
      View details
    • 09/06/17
      Cantor Fitzgerald
      overweight
      $17
    • 09/29/15
      JMP Securities
      market perform
    • 09/29/15
      Jefferies
      hold
      $2
    • 09/28/15
      Raymond James
      outperform
      $3
    • 09/28/15
      UBS
      neutral
      $2
    • 09/28/15
      Roth Capital
      neutral
      $2
      "There has been a major disappointment this morning as the pivotal COMMAND study using VS-6063 in..."
      View details
    • 09/28/15
      Mizuho
      neutral
      $2
      "We are downgrading VSTM from Buy to Neutral and lowering our PT from $21 to $2 following the..."
      View details
    • 05/14/15
      Zacks
      hold
    • 12/16/14
      Wells Fargo
      outperform
    • 08/08/14
      Guggenheim
      buy
      $21
    • 07/11/14
      Deutsche Bank
      buy
      $14
    • 100% positive
      $10 Median

    Best rated in Biotechnology last 7 days

    more

    Users who viewed VSTM also viewed

    more

    Best rated stocks last 7 days

    more

    Most rated stocks last 72 hrs

    more